The aim of our study was to ultilize combined radiomcis features extracted from T2-weighted MRI images as quantitative imaging biomarkers to differentiate neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS). Twenty-nine NMOSD patients and forty-five MS patients were enrolled. Our study showed 61 radiomics features and 8-feature-based radiomics signature were significantly different between NMOSD and MS. Therefore, radiomics may be an newly useful method which provides a promising non-invasive way of differentiating NMOSD and MS.
Introduction
Neuromyelitis optica spectrum disorder (NMOSD) has different pathophysiology, approaches to treatment and prognosis from multiple sclerosis (MS). 1,2 It is challenging to distinguish these two disorders by clinical manifestations and conventional neuroimaging, especially for the NMOSD patients with multiple brain lesions that are similar to MS.1,3 MRI, which is currently used for the diagnosis of NMOSD and MS, 4,5 is limited in signal intensity, lesion distribution, morphology. Radiomics which is known as the process of conversion of digital medical images into mineable high-dimensional data provides comprehensive quantification of region of interest ( ROI) by extracting and mining large number image features from medical images. 6-9 The aim of this study was to ultilize combined radiomcis features extracted from T2-weighted MRI images as quantitative imaging biomarkers to differentiate NMOSD and MS.Results and Discussion
There were no significant differences in age between MS (mean age, 38±10 years; 30 women) and NMOSD (mean age, 34±13 years; 27 women). Sixty-one radiomics features, most of which were the second order texture features calculated from the gray level co-occurrence matrix (GLCM), were significantly different (p value <0.05) between NMOSD and MS which revealed the potential discrimination power of texture analysis to be used for our object. The radiomics signature, which was combined with eight radiomics features (0_fos_uniformity, Max3D, 2_GLCM_contrast, 1_GLRLM_SRE, 4_GLCM_IDMN, 1_GLCM_maximum_probability, Surface_to_volume_ratio, and 2_GLCM_autocorrelation) from LASSO regression, was significantly different between the two groups (P<0.001), with area under ROC curve (AUC) of 0.826 (95%CI: 0.773-0.880) (Figure 3).Conclusion
In this study, Sixty-one radiomics features and 8-feature-based radiomics signature built by feature extraction and LASSO regression from T2WI were significantly different between NMOSD and MS. Therefore, radiomics may be an newly useful method which provides a promising non-invasive way of differentiating NMOSD and MS. Further study is warranted.1. Chawla S, Kister I, Wuerfel J, et al. Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI. AJNR American journal of neuroradiology. 2016 Jul;37(7):1223-30.
2. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. The Lancet. 2004;364(9451):2106-12.
3. Eshaghi A, Riyahi-Alam S, Saeedi R, et al. Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis. NeuroImage Clinical. 2015;7:306-14.
4. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015 Jul 14;85(2):177-89.
5. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of neurology. 2011 Feb;69(2):292-302.
6. Huang YQ, Liang CH, He L, et al. Development and validation of a radiomics nomogram for preoperative predicting lymph node metastasis in colorectal cancer. J Clin Oncol. 2016; 34(18): 2157-2164.
7. Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data1. Radiology. 2016;278:563-577.
8. Lambin, P, Rios-velazquez, E, Leijenaar, R. Radiomics?: Extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012; 48(4): 441–446.
9. Aerts, HJ, Velazquez, ER, Leijenaar, RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014; 5: 4006.